Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cognitive function in HIV-1-infected drug users.

G Shor-Posner1

  • 1Department of Psychiatry and Behavioral Sciences, University of Miami, Florida 33136, USA. gshor@mednet.med.miami.edu

Journal of Acquired Immune Deficiency Syndromes (1999)
|December 29, 2000
PubMed
Summary

Cognitive impairment is common in HIV-1 disease, affecting drug users and non-users alike. Further research is needed to identify early signs and effective interventions for HIV-associated neurocognitive disorders.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Can community health workers improve adherence to highly active antiretroviral therapy in the USA? A review of the literature.

HIV medicine·2011
Same author

Caregivers' perception of HIV-infected Dominican children's behaviour.

The West Indian medical journal·2007
Same author

Behavioural symptoms of children with HIV infection living in the Dominican Republic.

The West Indian medical journal·2007
Same author

Development of thrombocytosis in HIV+ drug users: impact of antiretroviral therapy.

Platelets·2002
Same author

Thrombocytopenia in HIV-infected drug users in the HAART era.

Platelets·2002
Same author

High-risk behaviours in men from Bogotá, Colombia and the spread of HIV.

International journal of STD & AIDS·2001

Area of Science:

  • Neuroscience
  • Infectious Diseases
  • Public Health

Background:

  • Cognitive ability loss is a frequent neuropsychological complication of HIV-1 infection.
  • This impairment impacts treatment adherence, functional capacity, and mortality risk.
  • Cognitive deficits in attention, memory, and processing are observed in HIV-1-infected individuals, including drug users.

Purpose of the Study:

  • To investigate early cognitive dysfunction in asymptomatic HIV-1-infected drug users.
  • To evaluate confounding factors influencing cognitive function in this population.
  • To explore potential neuroprotective therapies for HIV-1-associated cognitive impairment.

Main Methods:

  • Review of existing literature on HIV-1-associated cognitive impairment.

Related Experiment Videos

  • Analysis of studies examining drug users and non-drug users with HIV-1.
  • Consideration of confounding variables like drug abuse, age, education, and nutrition.

    • Main Results:

    • Cognitive impairment is reported in HIV-1-infected drug users, mirroring findings in non-drug users.
    • The presence of early cognitive dysfunction in asymptomatic HIV-1-infected drug users is debated.
    • Zidovudine therapy shows a time-limited protective effect against AIDS dementia.

    Conclusions:

    • Identifying early cognitive dysfunction in asymptomatic HIV-1-infected drug users requires careful consideration of confounding factors.
    • Further research is necessary to determine the efficacy of therapies like antioxidants and vitamins in preventing neuronal damage.
    • Understanding the etiology of cognitive deficits is crucial for effective management of HIV-1 disease.